Trevi Therapeutics Inc (TRVI)

Capital Expenditure

$13.24M

TTM · Period ending: · USD

TRVI logo

TRVI Capital Expenditure

Latest reported$13.24M
TRVI TTM CapEx (-$158.00K → $13.24M)
High-resolution chart · PNG

TRVI capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Trevi Therapeutics Inc Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
13,239,000
13,363,000
13,465,000
-19,000
-7,000
-35,000
-35,000
-50,000
-68,000
-80,000
-137,000
-231,000
-256,000
-216,000
-159,000
-43,000
0
0
0
-5,000
-20,000
-32,000
-32,000
-27,000
-12,000
0
-9,000
-101,000
-100,000
-110,000
-158,000
-66,013
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.